⏳ Fetching live dividend data...
Home › Calculator › JAZZ Dividend Calculator 2026
Jazz Pharmaceuticals plc · NASDAQ
Price: $236.49 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in JAZZ → $1.51M in 10 years · $7.14/month
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in narcolepsy patients seven years of age and older; Sunosi for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea; Erwinaze to treat acute lymphoblastic leukemia; Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease; Vyxeos liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia; and Zepzelca for the treatment of adult patients with metastatic small cell lung cancer. The company also offers Xywav, an oxybate product candidate, to treat EDS and cataplexy with narcolepsy and idiopathic hypersomnia; JZP-324, a low sodium oxybate formulation with the potential to provide a clinically meaningful option for narcolepsy patients; JZP385, a T-type calcium channel modulator, for the treatment of essential tremor; JZP458, a recombinant Erwinia asparaginase, for use as a component of a multi-agent chemotherapeutic regimen in the treatment of pediatric and adult patients; and JZP150 for treatment of post-traumatic stress disorder. The company has licensing and collaboration agreements with ImmunoGen, Inc.; Codiak BioSciences, Inc.; Pfenex, Inc.; XL-protein GmbH; and Redx Pharma plc. Jazz Pharmaceuticals plc was incorporated in 2003 and is headquartered in Dublin, Ireland.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open JAZZ position with:
Real after-tax yield depends on where you live and how you hold JAZZ.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.85% | -1.95% | $85 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.72% | -2.08% | $72 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.68% | -2.12% | $68 / yr |
| 🇬🇧 UK ISA | 0% | 0.85% | -1.95% | $85 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.78% | -2.02% | $78 / yr |
| 🇨🇦 TFSA | 0% | 0.85% | -1.95% | $85 / yr |
| 🇨🇦 CA Taxable | 25% | 0.64% | -2.16% | $64 / yr |
| 🇦🇺 Super (pension) | 15% | 0.72% | -2.08% | $72 / yr |
| 🇦🇺 AU Taxable | 30% | 0.59% | -2.21% | $59 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.63% | -2.17% | $63 / yr |
| 🇫🇷 FR Taxable | 30% | 0.59% | -2.21% | $59 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
JAZZ pays quarterly — 4 times per year. Next ex-div: TBD.
How JAZZ compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for JAZZ sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| G-Gift | 2026-06-03 | 600 | — | — | ||
| Sale | 2026-05-28 | 1,192 | $236.97 | $282.5K | ||
| M-Exempt | 2026-05-28 | 6,907 | $109.45 | $756.0K | ||
| Sale | 2026-05-28 | 6,907 | $235.41 | $1.63M | ||
| M-Exempt | 2026-05-28 | 6,907 | $109.45 | $756.0K | ||
| M-Exempt | 2026-05-28 | 3,415 | $138.08 | $471.5K | ||
| M-Exempt | 2026-05-28 | 3,415 | $138.08 | $471.5K | ||
| M-Exempt | 2026-05-22 | 3,415 | $138.08 | $471.5K | ||
| Sale | 2026-05-22 | 2,741 | $241.57 | $662.1K | ||
| M-Exempt | 2026-05-22 | 3,415 | $138.08 | $471.5K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the JAZZ dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →